Morgan Stanley’s Krystal Biotech KRYS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$32.2M Sell
234,421
-63,784
-21% -$8.77M ﹤0.01% 2339
2025
Q1
$53.8M Buy
298,205
+41,930
+16% +$7.56M ﹤0.01% 1750
2024
Q4
$40.1M Sell
256,275
-19,529
-7% -$3.06M ﹤0.01% 2043
2024
Q3
$50.2M Sell
275,804
-42,523
-13% -$7.74M ﹤0.01% 1818
2024
Q2
$58.5M Buy
318,327
+99,498
+45% +$18.3M ﹤0.01% 1610
2024
Q1
$38.9M Sell
218,829
-420,613
-66% -$74.8M ﹤0.01% 1993
2023
Q4
$79.3M Buy
639,442
+350,890
+122% +$43.5M ﹤0.01% 1968
2023
Q3
$33.5M Buy
288,552
+13,725
+5% +$1.59M ﹤0.01% 1936
2023
Q2
$32.3M Buy
274,827
+148,002
+117% +$17.4M ﹤0.01% 1990
2023
Q1
$10.2M Buy
126,825
+60,774
+92% +$4.87M ﹤0.01% 3124
2022
Q4
$5.23M Buy
66,051
+18,738
+40% +$1.48M ﹤0.01% 3727
2022
Q3
$3.3M Sell
47,313
-32,041
-40% -$2.23M ﹤0.01% 4028
2022
Q2
$5.21M Buy
79,354
+7,374
+10% +$484K ﹤0.01% 3713
2022
Q1
$4.79M Sell
71,980
-39,018
-35% -$2.6M ﹤0.01% 3739
2021
Q4
$7.76M Buy
110,998
+77,764
+234% +$5.44M ﹤0.01% 3229
2021
Q3
$1.74M Sell
33,234
-10,217
-24% -$534K ﹤0.01% 4676
2021
Q2
$2.95M Buy
43,451
+31,745
+271% +$2.16M ﹤0.01% 4310
2021
Q1
$901K Buy
11,706
+665
+6% +$51.2K ﹤0.01% 4796
2020
Q4
$663K Buy
11,041
+7,238
+190% +$435K ﹤0.01% 4904
2020
Q3
$163K Sell
3,803
-1,839
-33% -$78.8K ﹤0.01% 5209
2020
Q2
$234K Buy
5,642
+3,411
+153% +$141K ﹤0.01% 5001
2020
Q1
$96K Sell
2,231
-12,960
-85% -$558K ﹤0.01% 5202
2019
Q4
$841K Buy
15,191
+6,105
+67% +$338K ﹤0.01% 4635
2019
Q3
$315K Sell
9,086
-15,831
-64% -$549K ﹤0.01% 4906
2019
Q2
$1M Buy
24,917
+23,002
+1,201% +$927K ﹤0.01% 4219
2019
Q1
$63K Sell
1,915
-2,085
-52% -$68.6K ﹤0.01% 5565
2018
Q4
$83K Sell
4,000
-1,366
-25% -$28.3K ﹤0.01% 5616
2018
Q3
$94K Buy
5,366
+4,170
+349% +$73K ﹤0.01% 5707
2018
Q2
$18K Buy
+1,196
New +$18K ﹤0.01% 6175